Loading...
Chandra Bhagat Pharma Private Limited — Salbutamol Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Salbutamol · $1.4M export value · DGFT Verified
Chandra Bhagat Pharma Private Limited is the #9 Indian exporter of Salbutamol with $1.4M in export value and 40 verified shipments. Chandra Bhagat Pharma Private Limited holds a 0.9% market share in Salbutamol exports across 1 countries. The company exports 3 pharmaceutical products worth $1.8M across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $38.3M | 1,738 | 36.1% |
| SOUTH AFRICA | $15.1M | 301 | 14.2% |
| PHILIPPINES | $13.2M | 673 | 12.5% |
| SRI LANKA | $5.8M | 257 | 5.4% |
| COLOMBIA | $5.1M | 159 | 4.8% |
| MALAYSIA | $4.9M | 353 | 4.7% |
| NEW ZEALAND | $4.0M | 136 | 3.8% |
| UNITED ARAB EMIRATES | $3.8M | 1,024 | 3.5% |
| TANZANIA | $3.2M | 129 | 3.0% |
| TURKEY | $2.7M | 120 | 2.5% |
India exports Salbutamol to 164 countries. The top destination is BRAZIL (36.1%), followed by SOUTH AFRICA and PHILIPPINES.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LABORATORIO TEUTO BRASILEIRO S/A | BRAZIL | $23.9M | 1,150 |
| MEDPRO PHARMACEUTICA (PTY) LTD | SOUTH AFRICA | $9.2M | 184 |
| LABORATORIO TEUTO BRASILEIRO S A | BRAZIL | $8.3M | 294 |
| BREATHEFREE LANKA PVT LTD | SRI LANKA | $4.9M | 140 |
| CIPLA MALAYSIA SDN BHD |
India exported $130.8M worth of Salbutamol through 14,359 shipments from 602 suppliers to 164 countries, serving 1,775 buyers globally. Chandra Bhagat Pharma Private Limited contributes $1.4M to this total, accounting for 0.9% of India's Salbutamol exports.
Chandra Bhagat Pharma Private Limited's average Salbutamol shipment value is $33.9K per consignment, based on 40 shipments totaling $1.4M.
Chandra Bhagat Pharma Private Limited ranks #9 among 602 Indian Salbutamol exporters with a 0.9% market share. The top 3 exporters are CIPLA LIMITED ($100.3M), GLENMARK PHARMACEUTICALS LIMITED ($5.7M), AHLCON PARENTERALS (INDIA) LIMITED ($4.9M). Chandra Bhagat Pharma Private Limited processed 40 shipments to 1 destination countries.
What Chandra Bhagat Pharma Private Limited must comply with to export Salbutamol to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | AMANTA HEALTHCARE LIMITED | $2.0M | 43 | 4 | $46.3K |
| 8 | MGRM MEDICARE PRIVATE LIMITED | $1.8M | 54 | 1 | $34.2K |
| 9 | CHANDRA BHAGAT PHARMA PRIVATE LIMITED ★ | $1.4M | 40 | 1 | $33.9K |
| 10 | MACLEODS PHARMACEUTICALS LTD | $1.3M | 58 | 20 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,198 | 15.3% |
| SAHAR AIR | 2,141 | 14.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,530 | 10.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,497 | 10.4% |
| DELHI AIR | 1,064 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 1,036 | 7.2% |
| JNPT | 842 | 5.9% |
| Bombay Air | 568 | 4.0% |
Chandra Bhagat Pharma Private Limited exports 3 products worth $1.8M. Beyond Salbutamol, top products include Cyclosporine, Amikacin. View the complete Chandra Bhagat Pharma Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Salbutamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Chandra Bhagat Pharma Private Limited's Salbutamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Chandra Bhagat Pharma Private Limited
Full Company Profile →
3 products · $1.8M total trade · 3 categories
| MALAYSIA |
| $3.9M |
| 149 |
| PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR | TURKEY | $2.5M | 69 |
| ALLOGA UK LTD | UNITED KINGDOM | $2.5M | 88 |
| GLENMARK FARMACEUTICA LTDA. | BRAZIL | $2.0M | 40 |
| M/S I.E. MEDICA INC., | PHILIPPINES | $1.9M | 41 |
| M/S. MORAF PHARMACEUTICALS LTD | TANZANIA | $200.0K | 4 |
India's Salbutamol is purchased by 1,775 buyers worldwide. The top buyer is LABORATORIO TEUTO BRASILEIRO S/A (BRAZIL), followed by MEDPRO PHARMACEUTICA (PTY) LTD and LABORATORIO TEUTO BRASILEIRO S A.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| $22.2K |
| 11 | AGIO PHARMACEUTICALS LIMITED | $1.2M | 62 | 5 | $20.0K |
Chandra Bhagat Pharma Private Limited ranks #9 among 602 Indian Salbutamol exporters. Average shipment value of $33.9K compared to the market average of $217.4K. The closest competitors by value are AMANTA HEALTHCARE LIMITED and MGRM MEDICARE PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 164+ countries, 1,775+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Chandra Bhagat Pharma Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salbutamol. For current shipment-level data, contact TransData Nexus.